|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
KR101011373B1
(ko)
|
2002-07-11 |
2011-01-28 |
비큐론 파마슈티컬스 인코포레이티드 |
항균작용을 갖는 ｎ-히드록시아미드 유도체
|
|
AU2004204760C1
(en)
|
2003-01-08 |
2010-08-19 |
Novartis Vaccines And Diagnostics, Inc. |
Antibacterial agents
|
|
NZ544756A
(en)
|
2003-07-22 |
2009-09-25 |
Astex Therapeutics Ltd |
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
JP4667384B2
(ja)
*
|
2003-10-07 |
2011-04-13 |
レノビス， インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
|
MXPA06005989A
(es)
*
|
2003-12-19 |
2006-08-23 |
Basf Ag |
Fenilalanina-amidas sustituidas por benzoilo.
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
*
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
DK1841423T3
(da)
|
2005-01-26 |
2010-06-07 |
Allergan Inc |
Anvendelse af 1-benzyl-1-hydroxy-2,3-diamino-propylaminer, 3-benzyl-3-hydroxy-2-aminopropionsyre-amider og beslægtede forbindelser som analgetika
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
MX2007009381A
(es)
*
|
2005-02-28 |
2007-09-25 |
Renovis Inc |
Derivados de amida como ligandos de canales ionicos y composiciones farmaceuticas y metodos para usar los mismos.
|
|
SG171690A1
(en)
|
2005-03-22 |
2011-06-29 |
Harvard College |
Treatment of protein degradation disorders
|
|
AU2006268183B2
(en)
*
|
2005-07-11 |
2012-08-09 |
Wyeth |
Glutamate aggrecanase inhibitors
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
US8088804B2
(en)
|
2005-12-15 |
2012-01-03 |
Pfizer Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
JP5441416B2
(ja)
*
|
2006-02-14 |
2014-03-12 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二官能性ヒストンデアセチラーゼインヒビター
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
CN101460470B
(zh)
|
2006-05-30 |
2011-05-18 |
阿斯利康(瑞典)有限公司 |
作为dgat1抑制剂的1,3,4-二唑衍生物
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
|
CA2658877C
(en)
*
|
2006-07-24 |
2013-02-19 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors for the treatment of a microbial infection
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
CN101528711A
(zh)
|
2006-08-31 |
2009-09-09 |
先灵公司 |
可用作抗细菌剂的乙内酰脲衍生物
|
|
JP2010506843A
(ja)
*
|
2006-10-13 |
2010-03-04 |
エックスティーエル バイオファーマシューティカルズ リミテッド |
Ｈｃｖを治療するための化合物および方法
|
|
MX2009004279A
(es)
|
2006-10-30 |
2009-05-22 |
Chroma Therapeutics Ltd |
Hidroxamatos como inhibidores de histona desacetilasa.
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2008105515A1
(ja)
*
|
2007-02-28 |
2008-09-04 |
Taisho Pharmaceutical Co., Ltd. |
新規なヒドロキサム酸誘導体
|
|
EP2124562B1
(en)
|
2007-03-09 |
2016-04-20 |
Second Genome, Inc. |
Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
|
|
EP2170814B1
(en)
*
|
2007-06-12 |
2016-08-17 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
EP2234608A2
(en)
|
2007-12-11 |
2010-10-06 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
JP5662803B2
(ja)
|
2007-12-20 |
2015-02-04 |
アストラゼネカ アクチボラグ |
Ｄｇａｔ１阻害剤としてのカルバモイル化合物１９０
|
|
ES2408932T3
(es)
|
2008-06-25 |
2013-06-24 |
Merck Sharp & Dohme Corp. |
Síntesis y uso de agentes antibacterianos heterocíclicos
|
|
KR101708946B1
(ko)
|
2008-07-23 |
2017-02-21 |
다나-파버 캔서 인스티튜트 인크. |
탈아세틸화제 억제제 및 그것의 용도
|
|
JP5650642B2
(ja)
*
|
2008-08-01 |
2015-01-07 |
バイオキシネス ファーマシューティカルズ， インコーポレイテッド |
メチオニンアナログおよびそれらを使用する方法
|
|
AU2009279949A1
(en)
*
|
2008-08-04 |
2010-02-11 |
Merck Sharp & Dohme Corp. |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
US8722686B2
(en)
|
2008-09-19 |
2014-05-13 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
CA2763402A1
(en)
*
|
2009-05-25 |
2010-12-02 |
Chiesi Farmaceutici S.P.A. |
A therapeutic combination comprising a pulmonary surfactant and a steroid
|
|
AU2010261499A1
(en)
|
2009-06-19 |
2012-01-12 |
Astrazeneca Ab |
Pyrazine carboxamides as inhibitors of DGAT1
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
KR101736218B1
(ko)
|
2009-09-25 |
2017-05-16 |
오리존 지노믹스 에스.에이. |
라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
CA2899583A1
(en)
|
2009-12-16 |
2011-06-23 |
Pfizer Inc. |
N-linked hydroxamic acid derivatives useful as antibacterial agents
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
US9186337B2
(en)
|
2010-02-24 |
2015-11-17 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
ES2607081T3
(es)
|
2010-04-19 |
2017-03-29 |
Oryzon Genomics, S.A. |
Inhibidores de desmetilasa específica de lisina-1 y su uso
|
|
TWI543961B
(zh)
*
|
2010-04-20 |
2016-08-01 |
大正製藥股份有限公司 |
Novel hydroxamic acid derivatives
|
|
MX342288B
(es)
|
2010-04-22 |
2016-09-23 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
|
LT2598482T
(lt)
|
2010-07-29 |
2018-07-10 |
Oryzon Genomics, S.A. |
Demetilazės lsd1 inhibitoriai arilciklopropilamino pagrindu ir jų medicininis panaudojimas
|
|
WO2012031298A2
(en)
*
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
BR112013011693A2
(pt)
*
|
2010-11-10 |
2016-08-09 |
Achaogen Inc |
derivados de ácido hidroxâmico e seu uso no tratamento de infecções por bactérias
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
PE20140471A1
(es)
|
2011-01-04 |
2014-04-13 |
Novartis Ag |
Moduladores de la via del complemento y usos de los mismos
|
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP2678319B1
(en)
|
2011-02-22 |
2019-04-17 |
The General Hospital Corporation |
Antibiotic tolerance inhibitors
|
|
KR101593288B1
(ko)
|
2011-03-07 |
2016-02-11 |
화이자 인코포레이티드 |
항균제로서 유용한 플루오로-피리디논 유도체
|
|
CN103492368A
(zh)
|
2011-04-08 |
2014-01-01 |
辉瑞大药厂 |
用作抗菌剂的咪唑、吡唑和噻唑衍生物
|
|
AU2012238374B2
(en)
|
2011-04-08 |
2015-04-02 |
Pfizer Inc. |
Isoxazole derivatives useful as antibacterial agents
|
|
TW201315710A
(zh)
|
2011-09-12 |
2013-04-16 |
Achaogen Inc |
Ｎ－（（ｓ）－３－胺基－１－（羥胺基）－３－甲基－１－酮基丁－２－基）－４－（（（１ｒ，２ｒ）－２－（羥甲基）環丙基）丁－１，３－二炔基）苯甲醯胺之多晶型
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
EP3736265A1
(en)
|
2011-10-20 |
2020-11-11 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
|
SI2776394T1
(sl)
|
2011-10-20 |
2019-05-31 |
Oryzon Genomics, S.A. |
Spojine (hetero)aril ciklopropilamina kot inhibitorji LSD1
|
|
MX357561B
(es)
*
|
2012-02-16 |
2018-07-13 |
Rqx Pharmaceuticals Inc |
Antibióticos peptídicos lineales.
|
|
WO2013170165A1
(en)
|
2012-05-10 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN104640855B
(zh)
|
2012-06-28 |
2017-08-29 |
诺华股份有限公司 |
补体途经调节剂及其用途
|
|
US9388199B2
(en)
|
2012-06-28 |
2016-07-12 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
ES2647124T3
(es)
|
2012-06-28 |
2017-12-19 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
|
ES2710491T3
(es)
|
2012-06-28 |
2019-04-25 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
|
WO2014002052A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
AU2013288319A1
(en)
|
2012-07-12 |
2015-02-05 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
ES2728336T3
(es)
*
|
2013-03-15 |
2019-10-23 |
Fujifilm Toyama Chemical Co Ltd |
Nuevo derivado de ácido hidroxámico o sal del mismo
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
EP3041354A4
(en)
*
|
2013-08-16 |
2017-06-14 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024021A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
KR102447581B1
(ko)
|
2014-04-15 |
2022-09-28 |
버텍스 파마슈티칼스 인코포레이티드 |
낭포성 섬유증 막전도 조절자 매개 질환 치료용 약제학적 조성물
|
|
JP6514716B2
(ja)
|
2014-04-22 |
2019-05-15 |
ノバルティス アーゲー |
ＬｐｘＣ阻害剤としてのイソオキサゾリンヒドロキサム酸誘導体
|
|
AU2015316401A1
(en)
|
2014-09-12 |
2017-04-06 |
Fujifilm Toyama Chemical Co., Ltd. |
Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
|
|
RU2017112303A
(ru)
|
2014-09-12 |
2018-10-12 |
Тояма Кемикал Ко., Лтд. |
Способ применения комбинации нового производного гидроксамовой кислоты и антибактериального вещества
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
ES2756300T3
(es)
|
2014-12-16 |
2020-04-27 |
Novartis Ag |
Compuestos de ácido isoxazol hidroxámico como inhibidores de LpxC
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
EP3307725A1
(en)
|
2015-06-11 |
2018-04-18 |
Basilea Pharmaceutica International AG |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
AU2016367510A1
(en)
*
|
2015-12-08 |
2018-06-07 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
RU2746850C2
(ru)
|
2016-04-18 |
2021-04-21 |
Виворион Терапьютикс Аг |
Новые ингибиторы меприна альфа и бета
|
|
JP7012289B2
(ja)
*
|
2016-04-25 |
2022-02-14 |
デューク ユニバーシティ |
ベンゾイルグリシン誘導体およびその作製および使用の方法
|
|
AU2017283768B2
(en)
|
2016-06-14 |
2019-05-23 |
Novartis Ag |
Crystalline form of (R)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
|
|
EA201990070A1
(ru)
|
2016-06-21 |
2019-06-28 |
ОРИОН ОФТАЛМОЛОДЖИ ЭлЭлСи |
Производные алифатического пролинамида
|
|
UA124672C2
(uk)
|
2016-06-21 |
2021-10-27 |
Оріон Офтальмолоджі Ллс |
Гетероциклічні похідні пролінаміду
|
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
|
AR108864A1
(es)
|
2016-06-23 |
2018-10-03 |
Achaogen Inc |
Agentes antibacterianos
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
KR20190063473A
(ko)
|
2016-09-28 |
2019-06-07 |
블레이드 테라퓨틱스, 인크. |
칼페인 조정자 및 그 치료학적 용도
|
|
US11406617B2
(en)
*
|
2016-12-23 |
2022-08-09 |
Intervet Inc. |
Compounds for the treatment of bovine or swine respiratory disease
|
|
MX388647B
(es)
|
2016-12-23 |
2025-03-20 |
Intervet Int Bv |
Compuestos utiles para el tratamiento de una infeccion por mannheimia haemolytica o histophilus somni.
|
|
WO2018208985A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US11666555B2
(en)
|
2017-05-17 |
2023-06-06 |
Drexel University |
RelA inhibitors for biofilm disruption
|
|
ES3008911T3
(en)
|
2017-07-11 |
2025-03-25 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
CA3070427A1
(en)
*
|
2017-07-27 |
2019-01-31 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
US11498909B2
(en)
|
2018-02-10 |
2022-11-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
JP7495395B2
(ja)
*
|
2018-09-20 |
2024-06-04 |
ブラックスミス メディシンズ，インク． |
抗菌性化合物
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
ES3003232T3
(en)
|
2018-10-30 |
2025-03-10 |
Gilead Sciences Inc |
Compounds for inhibition of alpha4beta7 integrin
|
|
CA3114240C
(en)
|
2018-10-30 |
2023-09-05 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
CN112969687B
(zh)
|
2018-10-30 |
2024-08-23 |
吉利德科学公司 |
作为α4β7整合素抑制剂的喹啉衍生物
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
JP2022521600A
(ja)
*
|
2019-02-22 |
2022-04-11 |
シラ セラピューティック インコーポレイティッド |
吸入可能な治療剤
|
|
CN114222730B
(zh)
|
2019-08-14 |
2024-09-10 |
吉利德科学公司 |
用于抑制α4β7整合素的化合物
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
CR20220316A
(es)
|
2019-12-06 |
2022-10-07 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
JP7620649B2
(ja)
|
2020-06-10 |
2025-01-23 |
アリゴス セラピューティクス インコーポレイテッド |
コロナウイルス、ピコルナウイルス及びノロウイルス感染を治療するための抗ウイルス化合物
|
|
JP2024522292A
(ja)
|
2021-06-04 |
2024-06-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ナトリウムチャネルのモジュレーターとしてのｎ－（ヒドロキシアルキル（ヘテロ）アリール）テトラヒドロフランカルボキサミド
|
|
AU2022306289A1
(en)
|
2021-07-09 |
2024-01-18 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
MX2024003859A
(es)
|
2021-09-28 |
2024-05-21 |
Blacksmith Medicines Inc |
Inhibidores de lpxc y usos de estos.
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|